Our long-term implantable Continuous Blood Glucose Monitoring (CBGM) technology is gearing up to be a game-changer, unobtrusively integrating into everyday life. CBGM Technology Product under development and not available for commercial use.

Apr 2, 2024 · The CBGM sensor leverages well-established cardiovascular technology to directly measure blood glucose intravenously, providing more rapid glucose monitoring results without the 15-20-minute lag seen with interstitial glucose sensors.

Jun 5, 2024 · Highly accurate continuous blood glucose monitor demonstrates Mean Absolute Relative Difference (MARD) of 4.7% at Day 90. Continuous blood glucose monitor offers the potential for simplified, discreet and less intrusive glucose monitoring for people with diabetes

Glucotrack is on track to launch an innovative, fully implantable CBGM system. A small device placed under the skin, this technology is designed to offer continuous, accurate blood glucose monitoring for up to 2 years and beyond without the calibration, comfort, and wearability challenges associated with traditional CGM approaches.

Dec 3, 2024 · Unlike traditional continuous glucose monitors that measure glucose levels in interstitial fluid, Glucotrack’s CBGM measures glucose directly from blood, aiming to provide real-time readings without the lag time typically associated with interstitial glucose measurements.

Feb 4, 2025 · The CBGM is a long-term implantable device with no on-body external component, designed for three years of continuous, accurate blood glucose monitoring, offering a more convenient and less intrusive glucose monitoring solution.

Continuous Blood Glucose Monitor in a Chronic Ovine Model © Glucotrack, 2024 Background: Results: This study provides in vivo assessment of Glucotrack’s long-term implantable Continuous Blood Glucose Monitor (CBGM) in an ovine model.

Jul 31, 2024 · The Company is currently developing a long-term implantable continuous blood glucose monitoring system for people living with diabetes. Glucotrack’s CBGM is a long-term, implantable system that continually measures blood glucose levels with a sensor longevity of 2+ years, no on-body wearable component and with minimal calibration.

May 16, 2024 · The Glucotrack sensor, implanted in the epidural space of animals, closely tracked both blood glucose and a commercially available subcutaneous continuous glucose monitor (CGM) throughout the 30-day period.

At Glucotrack, we’re dedicated to providing you with the latest research and insights into diabetes management. Explore our collection of publications to discover groundbreaking studies, real-world evidence, and expert analysis in the field of continuous glucose monitoring (CGM) technology.